Technology
Health
Pharmaceutical

Amphastar Pharmaceuticals

$21.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.31 (1.48%) Today
-$0.13 (-0.61%) After Hours

Why Robinhood?

You can buy or sell AMPH and other stocks, options, ETFs, and crypto commission-free!

About

Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. Read More The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment manufactures and distributes recombinant human insulin and porcine insulin. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Employees
2,078
Headquarters
Rancho Cucamonga, California
Founded
1996
Market Cap
984.36M
Price-Earnings Ratio
474.27
Dividend Yield
0.00
Average Volume
201.09K
High Today
$21.34
Low Today
$20.92
Open Price
$21.11
Volume
38.18K
52 Week High
$25.43
52 Week Low
$15.04

Collections

Technology
Health
Pharmaceutical
2014 IPO
US
North America

News

Seeking AlphaMay 12

Amphastar Pharmaceuticals, Inc. Q1 2019 Results - Earnings Call Transcript

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Jason Shandell - President, General Counsel and Director William Peters - Chief Financial Officer, Treasurer and Senior Vice President of Finance Conference Call Participants David Maris - Wells Fargo Securities, LLC Gary Nachman - BMO Capital Markets David Amsellem - Piper Jaffray Companies Young Lee - Raymond James & Associates, Inc. David Steinberg - Jefferies LLC Gregory G...

26
Yahoo FinanceMay 10

Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019

RANCHO CUCAMONGA, Calif., May 10, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (AMPH) announced today that Jason Shandell, President and Bill Peters, CFO, will be presenting at the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2019 at 3:40 p.m. Pacific Time, Las Vegas, NV. This presentation will be made available with a live webcast and may be accessed by visiting Amphastar’s Pharmaceuticals website at http://ir.amphastar.com . This webcast will be available for 90...

6
Yahoo FinanceMay 9

Amphastar Pharmaceuticals Q1 Earnings and Revenues Surpass Estimates

Amphastar (AMPH) delivered earnings and revenue surprises of 233.33% and 6.36%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

5

Earnings

-$0.05
$0.01
$0.07
$0.13
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.